METHODS FOR OBTAINING POLY-ε-CAPROLACTONE FOR PRODUCING MICRO- AND NANOSCALE DRUG CARRIERS
Abstract:
Poly-ε-caprolactone due to favorable properties including biocompatibiity, miscibility and controlled degradation is promising material for long term drug-delivery devices preparation, especially in blend with other polymers. Commercially available polymer is synthesized without considering this way of utilization, and may contain potentially toxic residues of compounds used during polymerization process. Therefore, we attempt to summarize in this work available methods for synthesis of poly-ε-caprolactone using nontoxic reactants. The product properties important for polymer drug delivery system such as number average molecular weight and polydyspersity index (PDI) were included. Also we present known methods for purification of the polymer from catalyst residues, and other methods that may improve process of polymerization catalyzed by less active compounds.
Related Concept Videos
Electron Carriers
Over the many stages of cellular respiration, glucose breaks down into carbon dioxide and water. Electron carriers pick up electrons lost by glucose in these reactions, temporarily storing and releasing them into the electron...
Methods of Obtaining Topography
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Carrier Transport
Drift Current:
The drift of charge carriers is started by an external electric field (E). Charged particles, such as electrons and holes, experience an acceleration between collisions with lattice atoms. For electrons, this results in a drift velocity (vd) given by:
The ADP/ATP Carrier Protein
Therapeutic Drug Monitoring: Drug Analysis Methods


